These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22881720)

  • 1. Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy.
    Kang CS; Sun X; Jia F; Song HA; Chen Y; Lewis M; Chong HS
    Bioconjug Chem; 2012 Sep; 23(9):1775-82. PubMed ID: 22881720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies.
    Kang CS; Song HA; Milenic DE; Baidoo KE; Brechbiel MW; Chong HS
    Nucl Med Biol; 2013 Jul; 40(5):600-5. PubMed ID: 23541026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
    Kang CS; Chen Y; Lee H; Liu D; Sun X; Kweon J; Lewis MR; Chong HS
    Nucl Med Biol; 2015 Mar; 42(3):242-9. PubMed ID: 25487552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of (90)Y and (177)Lu.
    Chong HS; Sun X; Chen Y; Sin I; Kang CS; Lewis MR; Liu D; Ruthengael VC; Zhong Y; Wu N; Song HA
    Bioorg Med Chem; 2015 Mar; 23(5):1169-78. PubMed ID: 25648683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
    Chong HS; Song HA; Ma X; Milenic DE; Brady ED; Lim S; Lee H; Baidoo K; Cheng D; Brechbiel MW
    Bioconjug Chem; 2008 Jul; 19(7):1439-47. PubMed ID: 18564868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted α-radioimmunotherapy applications.
    Song HA; Kang CS; Baidoo KE; Milenic DE; Chen Y; Dai A; Brechbiel MW; Chong HS
    Bioconjug Chem; 2011 Jun; 22(6):1128-35. PubMed ID: 21604692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
    Chong HS; Ma X; Le T; Kwamena B; Milenic DE; Brady ED; Song HA; Brechbiel MW
    J Med Chem; 2008 Jan; 51(1):118-25. PubMed ID: 18062661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
    Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
    Price EW; Zeglis BM; Lewis JS; Adam MJ; Orvig C
    Dalton Trans; 2014 Jan; 43(1):119-31. PubMed ID: 24104523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3p-C-NETA: A versatile and effective chelator for development of Al
    Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
    Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
    Chong HS; Milenic DE; Garmestani K; Brady ED; Arora H; Pfiester C; Brechbiel MW
    Nucl Med Biol; 2006 May; 33(4):459-67. PubMed ID: 16720237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient synthesis and evaluation of bimodal ligand NETA.
    Chong HS; Song HA; Birch N; Le T; Lim S; Ma X
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3436-9. PubMed ID: 18445528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates.
    Dadwal M; Kang CS; Song HA; Sun X; Dai A; Baidoo KE; Brechbiel MW; Chong HS
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7513-5. PubMed ID: 22047687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of
    Pandey U; Kameswaran M; Gamre N; Dash A
    J Labelled Comp Radiopharm; 2019 Apr; 62(4):158-165. PubMed ID: 30663095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
    Price EW; Edwards KJ; Carnazza KE; Carlin SD; Zeglis BM; Adam MJ; Orvig C; Lewis JS
    Nucl Med Biol; 2016 Sep; 43(9):566-576. PubMed ID: 27419360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.
    Price EW; Zeglis BM; Cawthray JF; Ramogida CF; Ramos N; Lewis JS; Adam MJ; Orvig C
    J Am Chem Soc; 2013 Aug; 135(34):12707-21. PubMed ID: 23901833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Bifunctional Chelator 3p-
    Sun X; Kang CS; Sin I; Zhang S; Ren S; Wang H; Liu D; Lewis MR; Chong HS
    ACS Omega; 2020 Nov; 5(44):28615-28620. PubMed ID: 33195913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Dose Preparation of [
    Menon SR; Mitra A; Chakraborty A; Tawate M; Sahu S; Rakshit S; Gaikwad S; Dhotre G; Damle A; Banerjee S
    Cancer Biother Radiopharm; 2022 Jun; 37(5):384-402. PubMed ID: 35575711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.